DE69614127D1 - Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung - Google Patents
Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendungInfo
- Publication number
- DE69614127D1 DE69614127D1 DE69614127T DE69614127T DE69614127D1 DE 69614127 D1 DE69614127 D1 DE 69614127D1 DE 69614127 T DE69614127 T DE 69614127T DE 69614127 T DE69614127 T DE 69614127T DE 69614127 D1 DE69614127 D1 DE 69614127D1
- Authority
- DE
- Germany
- Prior art keywords
- inflammatory
- reverse transcriptase
- family
- inhibitors
- inhibit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52887995A | 1995-09-15 | 1995-09-15 | |
US08/600,525 US5705522A (en) | 1995-09-15 | 1996-02-13 | Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors |
PCT/IB1996/000942 WO1997010205A1 (en) | 1995-09-15 | 1996-09-13 | A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69614127D1 true DE69614127D1 (de) | 2001-08-30 |
Family
ID=27062862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69614127T Expired - Lifetime DE69614127D1 (de) | 1995-09-15 | 1996-09-13 | Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung |
Country Status (8)
Country | Link |
---|---|
US (1) | US5705522A (de) |
EP (1) | EP0854860B1 (de) |
JP (1) | JP2000511871A (de) |
AT (1) | ATE203513T1 (de) |
AU (1) | AU6835096A (de) |
CA (1) | CA2231996A1 (de) |
DE (1) | DE69614127D1 (de) |
WO (1) | WO1997010205A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194391B1 (en) * | 1998-06-24 | 2001-02-27 | Emory University | 3′-azido-2′,3′-dideoxyuridine administration to treat HIV and related test protocol |
SK11922002A3 (sk) * | 2000-02-18 | 2003-06-03 | Shire Biochem Inc. | Použitie analógov nukleozidov na liečenie alebo prevenciu infekcií spôsobených flavivírusom |
US20050087555A1 (en) * | 2003-10-28 | 2005-04-28 | Hatton Jason D. | Fluid dispensing components |
AU2006326404B2 (en) * | 2005-12-14 | 2011-11-03 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
PT2691530T (pt) | 2011-06-10 | 2018-05-10 | Univ Oregon Health & Science | Glicoproteínas e vectores recombinantes cmv |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ216172A (en) * | 1985-05-15 | 1989-08-29 | Wellcome Found | Nucleosides and pharmaceutical compositions |
JPS62501712A (ja) * | 1985-08-26 | 1987-07-09 | アメリカ合衆国 | 2′、3′―ジデオキシイノシン、2′,3′―ジデオキシグアノシンまたは2′,3′―ジデオキシアデノシンを含有する抗htlv―3/lav剤 |
US5254539A (en) * | 1985-08-26 | 1993-10-19 | U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health | Method of treating HIV with 2',3'-dideoxyinosine |
FR2646348A1 (fr) * | 1989-04-28 | 1990-11-02 | Inst Nat Sante Rech Med | D-aspartique acide-hydroxamate en tant que medicament |
US5571839A (en) * | 1989-04-28 | 1996-11-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | D-aspartic acid β-hydroxamate for the treatment of viral infections and tumors |
GB9208428D0 (en) * | 1992-04-16 | 1992-06-03 | Proteus Molecular Design | Synthetic polypeptides |
DE69433953T2 (de) * | 1993-05-21 | 2005-08-25 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Neues Verfahen zur Hemmung der Replikation der virusabhängigen reversen Transkriptase durch Verwendung von Didesoxynukleotid-Synthese Inhibitoren |
AU1249595A (en) * | 1993-12-20 | 1995-07-17 | Compagnie De Developpment | Mixtures of dideoxynucleosides and d-aspartic acid beta-hydroxamate for inhibiting retroviral spread |
-
1996
- 1996-02-13 US US08/600,525 patent/US5705522A/en not_active Expired - Fee Related
- 1996-09-13 AT AT96928647T patent/ATE203513T1/de not_active IP Right Cessation
- 1996-09-13 EP EP96928647A patent/EP0854860B1/de not_active Expired - Lifetime
- 1996-09-13 AU AU68350/96A patent/AU6835096A/en not_active Abandoned
- 1996-09-13 CA CA002231996A patent/CA2231996A1/en not_active Abandoned
- 1996-09-13 DE DE69614127T patent/DE69614127D1/de not_active Expired - Lifetime
- 1996-09-13 WO PCT/IB1996/000942 patent/WO1997010205A1/en active IP Right Grant
- 1996-09-13 JP JP09511797A patent/JP2000511871A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2000511871A (ja) | 2000-09-12 |
US5705522A (en) | 1998-01-06 |
ATE203513T1 (de) | 2001-08-15 |
EP0854860B1 (de) | 2001-07-25 |
AU6835096A (en) | 1997-04-01 |
WO1997010205A1 (en) | 1997-03-20 |
CA2231996A1 (en) | 1997-03-20 |
EP0854860A1 (de) | 1998-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0735890T3 (da) | Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning | |
DE3587434D1 (de) | Antivirale pharmazeutische zusammensetzungen und ihrer verwendung. | |
BG102048A (en) | Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors | |
KR880010777A (ko) | 바이러스 억제제와 결합한 dsRNA로 인간의 바이러스 감염을 치료하는 방법 | |
MX9403380A (es) | Inhibidores de proteasa de vih utiles para el tratamiento de sida. | |
ATE298741T1 (de) | Polyaromatische verbindungen zur behandlung von herpes-infektionen | |
ATE227133T1 (de) | Verwendung von interferon-alpha 8 subtype zur herstellung von medikamenten zur behandlung von viralinfektionen der leber | |
DE60022380D1 (de) | Verwendung von einem trifluridin derivat allein oder in kombination mit einem thymidin-phosphorylase-hemmer zur behandlung von hiv | |
PT88248A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo rnas de cadeia dupla com actividade topica | |
DE60036862D1 (de) | Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid-analoge | |
DE69614127D1 (de) | Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung | |
DE3686108T2 (de) | Verwendung von p-chlorophenoxyazetat von n,n-dimethylbiguanid zur behandlung von neuropathien und nervendegeneration. | |
AR009935A1 (es) | Un compuesto efectivo para inhibir aspartilproteasa, composiciones que lo incorporan y metodos para prevenir o tratar infecciones con hiv | |
KR890009389A (ko) | 바이러스를 억제시키는 방법 | |
ES2103577T3 (es) | Compuestos antiviricos de naftoquinona, composiciones que los contienen y utilizaciones de estos compuestos. | |
ES2113888T3 (es) | Sulfatos de dextrina como agentes anti hiv-1 y composicion de los mismos. | |
DE69232417T2 (de) | Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren | |
ES2134259T3 (es) | Compuestos antiviricos calanolidas, composiciones y utilizacion de los mismos. | |
DE3767308D1 (de) | Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels. | |
PA8441101A1 (es) | Composiciones farmaceuticas | |
ATE179601T1 (de) | Aufheben der resistenz von hiv-1 linien gegenüber zidovudine | |
FR2647792B1 (de) | ||
ATE114115T1 (de) | Verwendung von 5,6-dihydro-dibenz(b,e>azepin-6,11-dion-11-oxim n zur herstellungvon antiretroviralen mitteln. | |
GR1000618B (el) | Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων. | |
DE68929084D1 (de) | Arzneimittel zur Verhinderung einer Infektion mit dem für AIDS verantwortlichen Virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |